V. S. Moshkin et al. / Tetrahedron Letters 53 (2012) 3568–3572
3571
Me
N
Me
N
CO2Et
CO2Et
O
Ph
MeNHCH2CO2H
+
CO2Et
C6H10O
Me
N
CO2Et
O
5
Me
8
(37%)
11
(16%)
Me
N
Me
N
OH
CO2Et
O
MeNHCH2CO2H
C6H10
+
Me
O
CO2Et
O
O
O
N
O
O
Me
6
9
12
(17%)
(30%)
Me
N
Me
N
Me
N
OH
COPh
O
O
O
MeNHCH2CO2H
C6H10
+
+
COPh
O
O
OH
Ph
O
Ph
O
O
O
7
13 (7%)
10 (49%)
10'
Scheme 4. Another examples of nucleophilic properties of the nonstabilized azomethine ylide.
Their 1H NMR spectra resembled closely the spectrum of pyrroli-
done 2 and contained characteristic signals for the four protons
of the 2-pyrrolidone ring. Additionally, 13C, 1H–13C HMQC and
1H–1H NOESY NMR spectra were recorded for compounds 8–13.
Reactions of diethyl coumarin-3-phosphonate 1 and cyclohexa-
none with proline or glycine led to mixtures of more than five
products, according to 31P NMR spectroscopy. In the case of pro-
line, this may be explained by the formation of additional diaste-
reomers during the 1,3-dipolar cycloaddition and the presence of
3. (a) Anaç, O.; Güngör, F. Sß. Tetrahedron 2010, 66, 5931–5953; (b) Pinho e Melo, T.
M. V. D. Eur. J. Org. Chem. 2006, 2873–2888.
4. Cohen, N.; Blount, J. F.; Lopresti, R. J.; Trullinger, D. P. J. Org. Chem. 1979, 44,
4005–4007.
5. (a) Zheng, L.; Yang, F.; Dang, Q.; Bai, X. Org. Lett. 2008, 10, 889–892; (b) Mao, H.;
Wang, S.; Yu, R.; Lv, H.; Xu, R.; Pan, Y. J. Org. Chem. 2011, 76, 1167–1169; (c)
Zhang, C.; De, C. K.; Mal, R.; Seidel, D. J. Am. Chem. Soc. 2008, 130, 416–417; (d)
Deb, I.; Coiro, D. J.; Seidel, D. Chem. Commun. 2011, 47, 6473–6475.
6. (a) Zhang, C.; Seidel, D. J. Am. Chem. Soc. 2010, 132, 1798–1799; (b) Das, D.;
Richers, M. T.; Ma, L.; Seidel, D. Org. Lett. 2011, 13, 6584–6587; (c) Zhang, C.;
Das, D.; Seidel, D. Chem. Sci. 2011, 2, 233–236.
7. Moshkin, V. S.; Sosnovskikh, V. Ya.; Slepukhin, P. A.; Röschenthaler, G.-V.
Mendeleev Commun. 2012, 22, 29–31.
protons at the a-position of the pyrroline ring; in the case of gly-
8. General procedure:
A mixture of the corresponding coumarin or diethyl
cine—a less stable N-protonated intermediate ylide. We conclude
that further efforts should be directed to develop a more effective
catalyst for this new reaction to increase the yield of the desired
pyrrolidones and the scope of the amino acids.
Thus, we have reported a novel domino reaction consisting of
two successive attacks of the methylaminomethyl anion species
from sarcosine (via its C- and N-centers) to an activated alkene
to give substituted pyrrolidones. The nucleophilic properties of
nonstabilized azomethine ylides have been described for the first
time, and continued studies are in progress.
benzylidene malonate (1.0 mmol), cyclohexanone (0.10 g, 1.0 mmol), finely
ground sarcosine (0.27 g, 3.0 mmol) and DIPEA (0.06 g, 0.5 mmol) was refluxed
in dry toluene (3.3 mL) with magnetic stirring and removal of the water formed
by means of a Dean–Stark trap. Refluxing was continued for 24–48 h. The
resulting mixture was cooled to room temperature and filtered. The solution
was evaporated in vacuo to give a viscous mixture of crude products, which
were isolated by column chromatography on silica gel.
9. Diethyl [(3R⁄,4S⁄)-4-(2-hydroxyphenyl)-1-methyl-2-oxopyrrolidin-3-yl]phospho-
nate (2): This compound was prepared from coumarin 1 according to the
general procedure (48 h), except DIPEA was not employed. White crystals, yield
47%, mp 129–133 °C; IR: 3158, 1686, 1459, 1219, 1052, 1022, 774 cm–1 1H
;
NMR (400 MHz, CDCl3) d 1.20 (t, 3H, Me, J = 7.1 Hz), 1.28 (t, 3H, Me, J = 7.1 Hz),
2.86 (d, 3H, NMe, J = 1.5 Hz), 3.39 (dd, 1H, H-3, J = 21.9, 6.8 Hz), 3.47 (ddd, 1H,
5-CHH, J = 9.5, 5.7, 2.3 Hz), 3.73 (t, 1H, 5-CHH, J = 9.3 Hz), 3.90–4.00 (m, 1H, H-
4), 3.99–4.11 (m, 2H, OCH2), 4.19 (quin, 2H, OCH2, J = 7.1 Hz), 6.77 (t, 1H, H-50,
J = 7.5 Hz), 6.96 (dd, 1H, H-30, J = 8.0, 1.1 Hz), 7.04–7.11 (m, 2H, H-60, H-40), 8.76
(br s, 1H, OH); 13C NMR (101 MHz, CDCl3) d 16.3 (d, OCH2Me, J = 6.2 Hz), 16.4
(d, OCH2Me, J = 6.1 Hz), 30.0 (NMe), 35.3 (C4), 46.9 (d, C3, J = 143.5 Hz), 54.4 (d,
C5, J = 7.1 Hz), 62.8 (d, OCH2, J = 6.8 Hz), 63.5 (d, OCH2, J = 6.5 Hz), 116.6 (C30),
119.7 (C50), 127.5 (d, C10, J = 5.7 Hz), 128.6 (C60), 128.7 (C40), 155.2 (C20), 169.5
(d, C2, J = 3.0 Hz); 31P NMR (162 MHz, CDCl3) d 25.54 (PO(OEt)2). Anal. Calcd for
Acknowledgment
This work was supported financially by the DFG RO 362/50/1.
References and notes
C
15H22NO5Pꢀ0.5H2O: C, 53.57; H, 6.89; N, 4.16. Found: C, 53.52; H, 6.97; N, 4.20.
1. (a) Strecker, A. Liebigs Ann. Chem. 1862, 123, 363–365; (b) Schönberg, A.;
Moubasher, R. Chem. Rev. 1952, 50, 261–277; (c) Dose, K. Nature 1957, 179,
734–735; (d) Baddar, F. G. J. Chem. Soc. 1949, S163–S167; (e) Baddar, F. G. J.
Chem. Soc. 1950, 136–139.
10. (a) Zvejniece, L.; Svalbe, B.; Veinberg, G.; Grinberga, S.; Vorona, M.; Kalvinsh, I.;
Dambrova, M. Basic Clin. Pharmacol. Toxicol. 2011, 109, 407–412; (b) Kanes, S. J.;
Tokarczyk, J.; Siegel, S. J.; Bilker, W.; Abel, T.; Kelly, M. P. Neuroscience 2007,
144, 239–246.
2. (a) Rizzi, G. P. J. Org. Chem. 1970, 35, 2069–2072; (b) Grigg, R.; Thianpatanagul,
S. J. Chem. Soc., Chem. Commun. 1984, 180–181; (c) Grigg, R.; Aly, M. F.;
Sridharan, V.; Thianpatanagul, S. J. Chem. Soc., Chem. Commun. 1984, 182–183;
(d) Grigg, R.; Idle, J.; McMeekin, P.; Vipond, D. J. Chem. Soc., Chem. Commun.
1987, 49–51; (e) Grigg, R.; Idle, J.; McMeekin, P.; Surendrakumar, S.; Vipond, D.
J. Chem. Soc., Perkin Trans. 1 1988, 2703–2713; (f) Tsuge, O.; Kanemasa, S.; Ohe,
M.; Takenaka, S. Bull. Chem. Soc. Jpn. 1987, 60, 4079–4089; (g) Tsuge, O.;
Kanemasa, S. Adv. Heterocycl. Chem. 1989, 45, 231–344; (h) Pandey, G.;
Banerjee, P.; Gadre, S. R. Chem. Rev. 2006, 106, 4484–4517; (i) Nájera, C.;
Sansano, J. M. Curr. Org. Chem. 2003, 7, 1105–1150; (j) Coldham, I.; Hufton, R.
Chem. Rev. 2005, 105, 2765–2809; (k) Padwa, A.; Pearson, W. H. In Synthetic
Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and
Natural Products; Wiley: Chichester, 2002; Vol. 59, 169–252.
11. Janecki, T.; Wa˛sek, T. Tetrahedron 2004, 60, 1049–1055.
12. (3S⁄,4S⁄)-3-Benzoyl-4-(2-hydroxyphenyl)-1-methylpyrrolidin-2-one and 4-hydroxy
-2-methyl-4-phenyl-1,3a,4,9b-tetrahydrochromeno[3,4-c]pyrrol-3(2H)-one (10):
Pale-brown crystals, yield 49%, mp 82–87 °C; IR: 3159, 2927, 1660, 1455, 1259,
754, 686 cmꢁ1 1H NMR (400 MHz, CDCl3) (10, 85%) d 2.94 (s, 3H, NMe), 3.63 (dd,
;
1H, CHH, J = 9.7, 6.6 Hz), 3.82 (dd, 1H, CHH, J = 9.7, 8.9 Hz), 4.30 (dt, 1H, H-4,
J = 8.9, 6.9 Hz), 4.70 (d, 1H, H-3, J = 7.2 Hz), 6.85 (td, 1H, H-50, J = 7.4, 1.1 Hz), 6.87
(dd, 1H, H-30, J = 8.0, 1.1 Hz), 7.11 (ddd, 1H, H-40, J = 8.0, 7.4, 1.6 Hz), 7.14 (dd, 1H,
H-60, J = 7.4, 1.6 Hz), 7.41 (tt, 2H, H-300, H-500, J = 7.7, 1.6 Hz), 7.54 (ddt, 1H, H-400,
J = 8.0, 6.9, 1.3 Hz), 8.04 (dd, 2H, H-200, H-600, J = 8.5, 1.3 Hz); (100, 15%) d 2.84 (s,
3H, NMe), 3.37 (d, 1H, CHH, J = 9.7 Hz), 3.48 (br d, 2H, H-3a, H-9b, J = 3 Hz), 3.84–
3.89 (m, 1H, CHH), 6.92 (td, 1H, H-8, J = 7.5, 1.2 Hz), 7.03 (dd, 1H, H-6, J = 8.1,